Literature DB >> 18600498

Murine pulmonary response to chronic hypoxia is strain specific.

Yuji Tada1, Sven Laudi, Julie Harral, Michelle Carr, Charles Ivester, Nobuhiro Tanabe, Yuichi Takiguchi, Koichiro Tatsumi, Takayuki Kuriyama, William C Nichols, James West.   

Abstract

Information concerning the effects of genetic variation between different background strains on hemodynamic, morphometric, and gene expression response to hypoxia would be useful. Three strains of mice were kept in hypoxia and phenotyped followed by gene profiling analysis. Among the variables examined, hematocrit, right heart muscularization, and right ventricular systolic pressure showed a strain-specific effect. Increased gene expression of inflammatory, muscle, and angiogenesis genes were seen in all strains, though the specific genes changed varied among groups. These results suggest that different strains use different gene expression mechanisms to adapt to the challenge of chronic hypoxia, resulting in modified phenotypic changes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18600498      PMCID: PMC3769701          DOI: 10.1080/01902140802093204

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  21 in total

1.  Operation Everest III (Comex '97): modifications of cardiac function secondary to altitude-induced hypoxia. An echocardiographic and Doppler study.

Authors:  A Boussuges; F Molenat; H Burnet; E Cauchy; B Gardette; J M Sainty; Y Jammes; J P Richalet
Journal:  Am J Respir Crit Care Med       Date:  2000-01       Impact factor: 21.405

Review 2.  Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease.

Authors:  Robert Naeije
Journal:  Proc Am Thorac Soc       Date:  2005

Review 3.  Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia.

Authors:  Kurt R Stenmark; Steven H Abman
Journal:  Annu Rev Physiol       Date:  2005       Impact factor: 19.318

Review 4.  Gene expression profiling in pulmonary hypertension.

Authors:  Todd M Bull; Christopher D Coldren; Mark W Geraci; Norbert F Voelkel
Journal:  Proc Am Thorac Soc       Date:  2007-01

Review 5.  [Serotonin and pulmonary arterial hypertension].

Authors:  S Eddahibi; S Adnot
Journal:  Rev Mal Respir       Date:  2006-04       Impact factor: 0.622

6.  Preferable anesthetic conditions for echocardiographic determination of murine cardiac function.

Authors:  Yuji Kawahara; Kouichi Tanonaka; Takuya Daicho; Mikio Nawa; Ryo Oikawa; Yoshihisa Nasa; Satoshi Takeo
Journal:  J Pharmacol Sci       Date:  2005-09       Impact factor: 3.337

Review 7.  Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms.

Authors:  Kurt R Stenmark; Karen A Fagan; Maria G Frid
Journal:  Circ Res       Date:  2006-09-29       Impact factor: 17.367

8.  Cerebral angiogenic factors, angiogenesis, and physiological response to chronic hypoxia differ among four commonly used mouse strains.

Authors:  Nicole L Ward; Elizabeth Moore; Kristen Noon; Nicholas Spassil; Erica Keenan; Tammy L Ivanco; Joseph C LaManna
Journal:  J Appl Physiol (1985)       Date:  2007-01-18

Review 9.  Secondary pulmonary hypertension.

Authors:  Rahul Roy; Jonathan M Couriel
Journal:  Paediatr Respir Rev       Date:  2006-01-30       Impact factor: 2.726

10.  The Gene Ontology (GO) project in 2006.

Authors: 
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

View more
  13 in total

1.  Upregulation of transcription factor NRF2-mediated oxidative stress response pathway in rat brain under short-term chronic hypobaric hypoxia.

Authors:  Niroj Kumar Sethy; Manjulata Singh; Rajesh Kumar; Govindasamy Ilavazhagan; Kalpana Bhargava
Journal:  Funct Integr Genomics       Date:  2010-10-05       Impact factor: 3.410

2.  Effects of acute Rho kinase inhibition on chronic hypoxia-induced changes in proximal and distal pulmonary arterial structure and function.

Authors:  Rebecca R Vanderpool; Ah Ram Kim; Robert Molthen; Naomi C Chesler
Journal:  J Appl Physiol (1985)       Date:  2010-11-18

3.  Genotype-phenotype effects of Bmpr2 mutations on disease severity in mouse models of pulmonary hypertension.

Authors:  Andrea L Frump; Arunima Datta; Sampa Ghose; James West; Mark P de Caestecker
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

4.  Interaction between bone morphogenetic protein receptor type 2 and estrogenic compounds in pulmonary arterial hypertension.

Authors:  Joshua P Fessel; Xinping Chen; Andrea Frump; Santhi Gladson; Tom Blackwell; Christie Kang; Jennifer Johnson; James E Loyd; Anna Hemnes; Eric Austin; James West
Journal:  Pulm Circ       Date:  2013-12-02       Impact factor: 3.017

5.  Pluripotent hematopoietic stem cells augment α-adrenergic receptor-mediated contraction of pulmonary artery and contribute to the pathogenesis of pulmonary hypertension.

Authors:  Ryota Hashimoto; Gregg M Lanier; Vidhi Dhagia; Sachindra R Joshi; Allan Jordan; Ian Waddell; Rubin Tuder; Kurt R Stenmark; Michael S Wolin; Ivan F McMurtry; Sachin A Gupte
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-01-08       Impact factor: 5.464

6.  Author's Reply.

Authors:  Mita Das; Joshua Fessel; James West
Journal:  Pulm Circ       Date:  2013-04       Impact factor: 3.017

7.  A process-based review of mouse models of pulmonary hypertension.

Authors:  Mita Das; Joshua Fessel; Haiyang Tang; James West
Journal:  Pulm Circ       Date:  2012-10       Impact factor: 3.017

8.  Gene expression in BMPR2 mutation carriers with and without evidence of pulmonary arterial hypertension suggests pathways relevant to disease penetrance.

Authors:  James West; Joy Cogan; Mark Geraci; Linda Robinson; John Newman; John A Phillips; Kirk Lane; Barbara Meyrick; Jim Loyd
Journal:  BMC Med Genomics       Date:  2008-09-29       Impact factor: 3.063

9.  Gene expression in lungs of mice lacking the 5-hydroxytryptamine transporter gene.

Authors:  Daniel Crona; Julie Harral; Serge Adnot; Saadia Eddahibi; James West
Journal:  BMC Pulm Med       Date:  2009-05-10       Impact factor: 3.317

Review 10.  Microarray analysis in pulmonary hypertension.

Authors:  Julia Hoffmann; Jochen Wilhelm; Andrea Olschewski; Grazyna Kwapiszewska
Journal:  Eur Respir J       Date:  2016-04-13       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.